Construct: ORF TRCN0000492117

Construct Description:

Construct Type:
ORF
Other Identifiers:
ORF019779.2_s317c1
DNA Barcode:
CTAAGCTAACTACGGCGGTACGCC
Epitope Tag:
V5
Notes:
No stop codon in insert

Originally Annotated References:

Gene:
MAPK10 (5602)

Vector Information:

Vector Backbone:
pLX_317
Pol II Cassette 1:
SV40-PuroR
Pol II Cassette 2:
EF1a-TRCN0000492117
Selection Marker:
PuroR
Visible Reporter:
n/a
Epitope Tag:
n/a

Current transcripts matched by this ORF:

Taxon Gene Symbol Description Transcript Nuc. Match %[?] Prot. Match %[?] Match Diffs[?]
1 human 5602 MAPK10 mitogen-activated protein k... NM_002753.5 99.8% 99.7% 960G>A;1266_1267insG
2 human 5602 MAPK10 mitogen-activated protein k... XM_005263135.4 99.8% 99.7% 960G>A;1266_1267insG
3 human 5602 MAPK10 mitogen-activated protein k... XM_017008429.2 99.8% 99.7% 960G>A;1266_1267insG
4 human 5602 MAPK10 mitogen-activated protein k... XM_017008430.2 99.8% 99.7% 960G>A;1266_1267insG
5 human 5602 MAPK10 mitogen-activated protein k... XM_017008432.2 99.8% 99.7% 960G>A;1266_1267insG
6 human 5602 MAPK10 mitogen-activated protein k... XM_024454144.1 99.8% 99.7% 960G>A;1266_1267insG
7 human 5602 MAPK10 mitogen-activated protein k... XM_024454145.1 99.8% 99.7% 960G>A;1266_1267insG
8 human 5602 MAPK10 mitogen-activated protein k... XM_024454146.1 99.8% 99.7% 960G>A;1266_1267insG
9 human 5602 MAPK10 mitogen-activated protein k... XM_024454147.1 99.8% 99.7% 960G>A;1266_1267insG
10 human 5602 MAPK10 mitogen-activated protein k... XM_006714269.3 97.4% 97.8% (many diffs)
11 human 5602 MAPK10 mitogen-activated protein k... NM_001351625.2 90.8% 90.7% 0_1ins114;846G>A;1152_1153insG
12 human 5602 MAPK10 mitogen-activated protein k... XM_017008434.2 90.8% 90.7% 0_1ins114;846G>A;1152_1153insG
13 human 5602 MAPK10 mitogen-activated protein k... XM_017008435.2 90.8% 90.7% 0_1ins114;846G>A;1152_1153insG
14 human 5602 MAPK10 mitogen-activated protein k... XM_017008436.2 90.8% 90.7% 0_1ins114;846G>A;1152_1153insG
15 human 5602 MAPK10 mitogen-activated protein k... XM_017008437.2 90.8% 90.7% 0_1ins114;846G>A;1152_1153insG
16 human 5602 MAPK10 mitogen-activated protein k... NM_138982.4 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
17 human 5602 MAPK10 mitogen-activated protein k... XM_005263129.3 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
18 human 5602 MAPK10 mitogen-activated protein k... XM_005263130.3 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
19 human 5602 MAPK10 mitogen-activated protein k... XM_011532117.3 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
20 human 5602 MAPK10 mitogen-activated protein k... XM_011532118.3 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
21 human 5602 MAPK10 mitogen-activated protein k... XM_017008420.2 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
22 human 5602 MAPK10 mitogen-activated protein k... XM_024454139.1 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
23 human 5602 MAPK10 mitogen-activated protein k... XM_024454140.1 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
24 human 5602 MAPK10 mitogen-activated protein k... XM_024454141.1 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
25 human 5602 MAPK10 mitogen-activated protein k... XM_024454142.1 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
26 human 5602 MAPK10 mitogen-activated protein k... XM_024454143.1 90.1% 89.8% 960G>A;1249_1250insCAGCA;1262_1392delinsG
27 human 5602 MAPK10 mitogen-activated protein k... NM_001363657.2 88.5% 88.8% (many diffs)
28 human 5602 MAPK10 mitogen-activated protein k... NM_001318067.1 88.1% 88.1% (many diffs)
29 human 5602 MAPK10 mitogen-activated protein k... XM_005263131.3 88.1% 88.1% (many diffs)
30 human 5602 MAPK10 mitogen-activated protein k... NM_001318069.2 87.5% 89.8% 960G>A;1249_1250insCAGCA;1262_1434delinsG
31 human 5602 MAPK10 mitogen-activated protein k... XM_017008441.2 85.1% 84.8% (many diffs)
32 human 5602 MAPK10 mitogen-activated protein k... XM_017008422.2 85% 84.4% (many diffs)
33 human 5602 MAPK10 mitogen-activated protein k... NM_001351624.2 82% 81.6% (many diffs)
34 human 5602 MAPK10 mitogen-activated protein k... NM_138980.4 82% 81.6% (many diffs)
35 human 5602 MAPK10 mitogen-activated protein k... XM_006714268.3 82% 81.6% (many diffs)
36 human 5602 MAPK10 mitogen-activated protein k... XM_011532120.3 82% 81.6% (many diffs)
37 human 5602 MAPK10 mitogen-activated protein k... XM_011532121.3 82% 81.6% (many diffs)
38 human 5602 MAPK10 mitogen-activated protein k... XM_017008423.2 82% 81.6% (many diffs)
39 human 5602 MAPK10 mitogen-activated protein k... XM_017008427.2 79.9% 79.9% (many diffs)
40 human 5602 MAPK10 mitogen-activated protein k... XM_017008428.2 79.9% 79.9% (many diffs)
41 human 5602 MAPK10 mitogen-activated protein k... XM_017008433.2 76.8% 76.2% (many diffs)
42 human 5602 MAPK10 mitogen-activated protein k... XM_017008451.2 72.8% 72.8% 0_1ins342;618G>A;924_925insG
43 human 5599 MAPK8 mitogen-activated protein k... NM_001323302.2 72.5% 83.9% (many diffs)
44 human 5599 MAPK8 mitogen-activated protein k... NM_001323324.2 72.5% 83.9% (many diffs)
45 human 5599 MAPK8 mitogen-activated protein k... NM_001323326.2 72.5% 83.9% (many diffs)
46 human 5599 MAPK8 mitogen-activated protein k... NM_001323327.2 72.5% 83.9% (many diffs)
47 human 5599 MAPK8 mitogen-activated protein k... NM_001323321.2 70.5% 82.7% (many diffs)
48 human 5599 MAPK8 mitogen-activated protein k... NM_001323325.2 70.5% 82.7% (many diffs)
49 human 5599 MAPK8 mitogen-activated protein k... NM_139046.4 70.5% 82.7% (many diffs)
50 human 5599 MAPK8 mitogen-activated protein k... XM_024448080.1 70.5% 82.7% (many diffs)
51 human 5602 MAPK10 mitogen-activated protein k... XM_017008445.2 65.7% 65.3% (many diffs)
52 human 5602 MAPK10 mitogen-activated protein k... XM_017008452.2 65.5% 65.4% 0_1ins435;525G>A;831_832insG
53 human 5599 MAPK8 mitogen-activated protein k... NM_001323328.2 65.3% 75.4% (many diffs)
54 human 5599 MAPK8 mitogen-activated protein k... NM_001323329.2 65.3% 75.4% (many diffs)
55 human 5599 MAPK8 mitogen-activated protein k... NM_001323331.2 65.3% 75.4% (many diffs)
56 human 5599 MAPK8 mitogen-activated protein k... NM_139049.4 65.3% 75.4% (many diffs)
57 human 5602 MAPK10 mitogen-activated protein k... XM_017008447.2 59% 58.6% (many diffs)
58 human 5602 MAPK10 mitogen-activated protein k... XM_017008448.2 59% 58.6% (many diffs)
59 human 5602 MAPK10 mitogen-activated protein k... XM_017008453.2 58.8% 57.6% (many diffs)
60 human 5602 MAPK10 mitogen-activated protein k... XM_017008454.2 57.7% 57.4% 731_732delGAinsTG;735_735delGins533
61 human 5602 MAPK10 mitogen-activated protein k... XM_024454149.1 57.7% 57.4% 731_732delGAinsTG;735_735delGins533
62 human 5602 MAPK10 mitogen-activated protein k... NM_001318068.1 57.1% 56.8% (many diffs)
63 human 5602 MAPK10 mitogen-activated protein k... XM_017008449.2 57.1% 56.8% (many diffs)
64 human 5602 MAPK10 mitogen-activated protein k... XM_017008450.2 57.1% 56.8% (many diffs)
65 human 5602 MAPK10 mitogen-activated protein k... XM_024454148.1 57.1% 56.8% (many diffs)
66 human 5599 MAPK8 mitogen-activated protein k... NM_001323320.2 51.5% 60.6% (many diffs)
67 human 5602 MAPK10 mitogen-activated protein k... XR_001741289.1 46.3% 1_6delGTATTT;736_1425del;1605_1606ins358
68 mouse 26414 Mapk10 mitogen-activated protein k... NM_009158.3 91.2% 99.2% (many diffs)
69 mouse 26414 Mapk10 mitogen-activated protein k... NM_001318131.1 89% 97.6% (many diffs)
70 mouse 26414 Mapk10 mitogen-activated protein k... XM_006534950.4 89% 97.6% (many diffs)
71 mouse 26414 Mapk10 mitogen-activated protein k... NM_001310686.2 82.4% 90.7% (many diffs)
72 mouse 26414 Mapk10 mitogen-activated protein k... XM_017320890.2 82.4% 90.7% (many diffs)
73 mouse 26414 Mapk10 mitogen-activated protein k... XM_017320891.2 82.4% 90.7% (many diffs)
74 mouse 26414 Mapk10 mitogen-activated protein k... NM_001081567.2 82.3% 89.4% (many diffs)
75 mouse 26414 Mapk10 mitogen-activated protein k... XM_030254516.1 82.3% 89.4% (many diffs)
76 mouse 26414 Mapk10 mitogen-activated protein k... NM_001310685.1 80.4% 87.9% (many diffs)
77 mouse 26414 Mapk10 mitogen-activated protein k... XM_017320886.2 80.4% 87.9% (many diffs)
78 mouse 26414 Mapk10 mitogen-activated protein k... XM_030254519.1 80.3% 89.1% (many diffs)
79 mouse 26414 Mapk10 mitogen-activated protein k... NM_001318102.1 79.9% 89.4% (many diffs)
80 mouse 26414 Mapk10 mitogen-activated protein k... NM_001310683.1 74.4% 81.6% (many diffs)
81 mouse 26414 Mapk10 mitogen-activated protein k... XM_017320888.2 74.4% 81.6% (many diffs)
82 mouse 26419 Mapk8 mitogen-activated protein k... NM_016700.4 72.8% 83.9% (many diffs)
83 mouse 26414 Mapk10 mitogen-activated protein k... XM_017320889.2 72.5% 80.1% (many diffs)
84 mouse 26414 Mapk10 mitogen-activated protein k... XM_011249450.3 67% 72.8% (many diffs)
85 mouse 26414 Mapk10 mitogen-activated protein k... XM_030254518.1 65.2% 71.3% (many diffs)
Download CSV

Sequence Information

Note: uppercase bases indicate empirically verified sequence.

ORF start:
72
ORF end:
1341
ORF length:
1269
Sequence:
1tcttccattt caggtgtcgt gaggctagca tcgattgatc aacaagtttg tacaaaaaag
61caggcttcac catgagcctc catttcttat actactgcag tgaaccaaca ttggatgtga
121aaattgcctt ttgtcaggga ttcgataaac aagtggatgt gtcatatatt gccaaacatt
181acaacatgag caaaagcaaa gttgacaacc agttctacag tgtggaagtg ggagactcaa
241ccttcacagt tctcaagcgc taccagaatc taaagcctat tggctctggg gctcagggca
301tagtttgtgc cgcgtatgat gctgtccttg acagaaatgt ggccattaag aagctcagca
361gaccctttca gaaccaaaca catgccaaga gagcgtaccg ggagctggtc ctcatgaagt
421gtgtgaacca taaaaacatt attagtttat taaatgtctt cacaccccag aaaacgctgg
481aggagttcca agatgtttac ttagtaatgg aactgatgga tgccaactta tgtcaagtga
541ttcagatgga attagaccat gagcgaatgt cttacctgct gtaccaaatg ttgtgtggca
601ttaagcacct ccattctgct ggaattattc acagggattt aaaaccaagt aacattgtag
661tcaagtctga ttgcacattg aaaatcctgg actttggact ggccaggaca gcaggcacaa
721gcttcatgat gactccatat gtggtgacac gttattacag agcccctgag gtcatcctgg
781ggatgggcta caaggagaac gtggatatat ggtctgtggg atgcattatg ggagaaatgg
841ttcgccacaa aatcctcttt ccaggaaggg actatattga ccagtggaat aaggtaattg
901aacaactagg aacaccatgt ccagaattca tgaagaaatt gcaaccCACA GTAAGAAACT
961ATGTGGAGAA TCGGCCCAAG TATGCGGGAC TCACCTTCCC CAAACTCTTC CCAGATTCCC
1021TCTTCCCAGC AGACTCCGAG CACAATAAAC TCAAAGCCAG CCAAGCCAGG GACTTGTTGT
1081CAAAGATGCT AGTGATTGAC CCAGCAAAAA GAATATCAGT GGACGACGCC TTACAGCATC
1141CCTACATCAA CGTCTGGTAT GACCCAGCCG AAGTGGAGGC GCCTCCACCT CAGATATATG
1201ACAAGCAGTT GGATGAAAGA GAACACACAA TTGAAGAATG GAAAGAACTT ATCTACAAGG
1261AAGTAATGAA TTCAGAAGAA AAGACTAAAA ATGGTGTAGT AAAAGGACAG CCTTCTCCTT
1321CAGCACAGGT GCAGCAGGAC CCAGCTTTCT TGTACAAAGT GGTTGATATC GGTAAGCCTA
1381TCCCTAACCC TCTCCTCGGT CTCGATTCTA CGTAGTAATG AACTAGTCCG TAACTTGAAA
1441GTATTTCGAT TTCTTGGCTT TATATATCTT GTGGAAAGGA CGACTAAGCT AACTACGGCG
1501GTACGCCACG CGTTAAGTCg acaatcaacc tctggattac aaaatttgtg aaagatt

Download FASTA (ORF) (Full)

GPP Web Portal Terms of Service

Effective Date: December 8, 2025
By using this site, you agree to our terms and conditions below.

Overview of Terms

The data made available on this website were generated for research purposes and are not intended for clinical or commercial uses. Commercial use (or other use for profit-making purposes) of the GPP Web Portal and its tools, is not permitted under these terms and may require a separate license agreement from Broad or its contributors. For more information, please contact partnering@broadinstitute.org.

The original data may be subject to rights claimed by third parties, including but not limited to, patent, copyright, other intellectual property rights, biodiversity-related access and benefit-sharing rights. It is the responsibility of users of Broad Institute services to ensure that their use of the data does not infringe any of the rights of such third parties.

Any questions or comments concerning these Terms of Use can be addressed to: legal@broadinstitute.org.

By accessing and viewing this GPP Web Portal, you agree to the following terms and conditions:

Attribution

You agree to acknowledge the Broad Institute (e.g., in publications, services or products) for any of your use of its online services, databases or software in accordance with good scientific practice. You agree to use the acknowledgment wording provided for the relevant tools as indicated on the FAQ for each tool.

Updating the Terms of Use

We reserve the right to update these Terms of Use at any time. When alterations are inevitable, we will attempt to give reasonable notice of any changes by placing a notice on our website, but you may wish to check each time you use the website. The date of the most recent revision will appear on this, the "GPP Web Portal Terms of Use" page. If you do not agree to these changes, please do not continue to use our online services. We will also make available an archived copy of the previous Terms of Use for comparison.

Indemnification and Disclaimer of Warranties

You are using this GPP Web Portal at your own risk, and you hereby agree to hold Broad and its contributors and their trustees, directors, officers, employees, and affiliated investigators harmless for any third party claims which may arise from your use of the GPP Web Portal, the tools available therein, or any portion thereof. Further, you agree to indemnify Broad, its contributors, and its and their trustees, directors, officers, employees, affiliated investigators, students, and affiliates for any loss, costs, claims, damages, or other liabilities arising from any unpermitted commercial or profit-making use you make of the GPP Web Portal. The GPP Web Portal is a research tool and is provided "as is". Broad does not represent that the GPP Web Portal is free of errors or bugs or suitable for any particular tasks.

ANY EXPRESS OR IMPLIED WARRANTIES, INCLUDING, BUT NOT LIMITED TO, THE IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS ARE DISCLAIMED. IN NO EVENT SHALL BROAD OR ITS CONTRIBUTORS BE LIABLE FOR ANY DIRECT, INDIRECT, INCIDENTAL, SPECIAL, EXEMPLARY, OR CONSEQUENTIAL DAMAGES HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY, WHETHER IN CONTRACT, STRICT LIABILITY, OR TORT (INCLUDING NEGLIGENCE OR OTHERWISE) ARISING IN ANY WAY OUT OF THE USE OF THE GPP WEB PORTAL, EVEN IF ADVISED OF THE POSSIBILITY OF SUCH DAMAGE.

Governing Law

The terms and conditions herein shall be construed, governed, interpreted, and applied in accordance with the internal laws of the Commonwealth of Massachusetts, U.S.A. Furthermore, by accessing, downloading, or using the Database, You consent to the personal jurisdiction of, and venue in, the state and federal courts within Massachusetts with respect to Your download or use of the Database.